VRCA

Verrica Pharmaceuticals

• TipRanks·1d ago

  Verrica’s COVE-3 Wart Study Moves Forward, Offering a Small but Notable Catalyst for VRCA and VEEV

• TipRanks·1d ago

  Verrica Shareholders Approve Governance Measures at Annual Meeting

• PUBT·1d ago

  Verrica Pharmaceuticals shareholders approve amended 2018 equity incentive plan at annual meeting

• PUBT·05/28 12:09

  Verrica Pharma CEO Jayson Rieger to present at Jefferies Global Healthcare Conference

• Dow Jones·05/26 11:01

  Verrica Pharmaceuticals Coverage Assumed by HC Wainwright & Co. at Buy

• Dow Jones·05/26 11:01

  Verrica Pharmaceuticals Price Target Announced at $12.00/Share by HC Wainwright & Co.

• Benzinga·05/26 10:51

  HC Wainwright & Co. Assumes Verrica Pharmaceuticals at Buy, Announces Price Target of $12

• TipRanks·05/26 10:19

  Verrica Pharmaceuticals assumed with a Buy at H.C. Wainwright

• Reuters·05/26 10:14

  VERRICA PHARMACEUTICALS INC <VRCA.O>: H.C. WAINWRIGHT ASSUMES COVERAGE WITH BUY RATING; TARGET PRICE $12

• Reuters·05/26 07:31

  U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy

• PUBT·05/21 05:07

  Lytix Biopharma Q1 net loss widens to NOK 25.95 million

• TipRanks·05/14 00:29

  Verrica Pharmaceuticals Earnings Call Highlights Growth, Strain

• PUBT·05/13 12:03

  Verrica CEO presents at H.C. Wainwright BioConnect Investor Conference at NASDAQ

• TipRanks·05/13 11:30

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sionna Therapeutics, Inc. (SION), Verrica Pharmaceuticals (VRCA) and Arvinas Holding Company (ARVN)

• Benzinga·05/13 09:16

  Transcript: Verrica Pharmaceuticals Q1 2026 Earnings Conference Call